Sansum Diabetes Research Institute (SDRI) has released its 2020 Annual Report, highlighting the efforts to improve the lives of people with diabetes through research, education, and clinical care.

SDRI has been respected globally for more than seven decades, and the 2020 Annual Report features the work that was accomplished in diabetes research, as well as the innovative approach the organization took during the COVID-19 pandemic to continue clinical research.

“In 2020, as COVID-19 disrupted the world, SDRI quickly responded to the immediate needs of the diabetes community without interruption,” said Ellen Goodstein, executive director. “In 2020, we continued our research and conducted 45 clinical research trials with 4,452 research participants and treated 170 women who lived with diabetes during pregnancy.

“I hope you enjoy reading about our progress, and we invite you to join us in feeling inspired and hopeful that together we will continue the work begun by Dr. William Sansum 77 years ago.”
The unique strategies SDRI implemented in 2020 to help people living with diabetes survive the unprecedented global health crisis are highlighted in the report. The report also features key activities that have impacted people living with diabetes in the Santa Barbara community, such as providing bilingual diabetes education that ranges from nutrition and exercise to healthy living.

The report showcases these programs offered for children, adults and seniors impacted by type 1 and type 2 diabetes, as well as gestational diabetes.

The research and programs featured in the 2020 Annual Report include artificial pancreas clinical research; novel therapeutics for people with type 2 diabetes; education for women with diabetes in pregnancy; Mil Familias, a longitudinal observational cohort studies enrolling Latino families with type 2 diabetes; bilingual diabetes education; Farming For Life, a program that provides locally sourced fresh vegetables at no cost to underserved people with or at risk of type 2 diabetes; and the community outreach efforts for people living with both type 1 and type 2 diabetes.

The report underscores SDRI’s key supporters and donors whose generosity helped facilitate new ideas, new research, and the ability to continue Dr. Sansum’s legacy in diabetes research.
To view SDRI’s Annual Report, visit